Berliner Boersenzeitung - Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma

EUR -
AED 3.961949
AFN 75.517905
ALL 101.159776
AMD 434.752707
ANG 1.944141
AOA 894.115856
ARS 391.678248
AUD 1.645463
AWG 1.944591
AZN 1.834067
BAM 1.950142
BBD 2.178101
BDT 118.665702
BGN 1.952444
BHD 0.406704
BIF 3074.665126
BMD 1.07883
BND 1.444821
BOB 7.454613
BRL 5.32144
BSD 1.07878
BTN 89.871661
BWP 14.696835
BYN 3.553523
BYR 21145.065429
BZD 2.174462
CAD 1.464076
CDF 2831.928367
CHF 0.944073
CLF 0.034417
CLP 950.718698
CNY 7.710501
COP 4331.696113
CRC 569.342824
CUC 1.07883
CUP 28.588992
CVE 110.633722
CZK 24.356203
DJF 191.729967
DKK 7.455966
DOP 61.271373
DZD 145.080363
EGP 33.227207
ERN 16.182448
ETB 60.121306
FJD 2.416309
FKP 0.854166
GBP 0.856753
GEL 2.936928
GGP 0.854166
GHS 12.946568
GIP 0.854166
GMD 72.632198
GNF 9288.724864
GTQ 8.446415
GYD 225.692495
HKD 8.43618
HNL 26.618768
HRK 7.596656
HTG 142.686009
HUF 379.702262
IDR 16694.298864
ILS 4.014812
IMP 0.854166
INR 89.90844
IQD 1413.267128
IRR 45607.532689
ISK 150.507778
JEP 0.854166
JMD 167.300021
JOD 0.765319
JPY 158.771931
KES 165.38223
KGS 96.355368
KHR 4443.700078
KMF 488.116845
KPW 970.923897
KRW 1418.839297
KWD 0.333218
KYD 0.899021
KZT 497.502679
LAK 22343.963816
LBP 16214.082275
LKR 353.924601
LRD 202.981769
LSL 20.077608
LTL 3.185504
LVL 0.652573
LYD 5.201907
MAD 10.905355
MDL 19.094219
MGA 4931.645546
MKD 61.441732
MMK 2265.400632
MNT 3725.641608
MOP 8.686878
MRO 385.142078
MUR 47.748265
MVR 16.57089
MWK 1815.989978
MXN 18.758043
MYR 5.041379
MZN 68.235935
NAD 20.076789
NGN 865.221727
NIO 39.485436
NOK 11.773243
NPR 143.794458
NZD 1.758099
OMR 0.415336
PAB 1.078805
PEN 4.047718
PGK 4.075101
PHP 59.753182
PKR 307.196383
PLN 4.3236
PYG 7975.785022
QAR 3.92775
RON 4.964755
RSD 116.911874
RUB 97.323938
RWF 1344.222017
SAR 4.046355
SBD 9.144104
SCR 14.443365
SDG 648.376447
SEK 11.307745
SGD 1.446824
SHP 1.312666
SLE 24.419619
SLL 21306.89001
SOS 616.548642
SRD 40.785517
STD 22329.600136
SYP 14026.785382
SZL 20.076786
THB 38.072224
TJS 11.795966
TMT 3.775905
TND 3.358391
TOP 2.544582
TRY 31.165086
TTD 7.309724
TWD 34.018758
TZS 2697.074752
UAH 39.581841
UGX 4094.159103
USD 1.07883
UYU 42.057972
UZS 13257.534415
VEF 3833824.348968
VES 38.33746
VND 26204.777514
VUV 128.587661
WST 2.93437
XAF 654.074417
XAG 0.044704
XAU 0.000534
XCD 2.915592
XDR 0.809459
XOF 648.37674
XPF 118.509744
YER 270.084879
ZAR 20.460084
ZMK 9710.766335
ZMW 25.862722
ZWL 347.382778
  • CMSC

    0.1000

    24.58

    +0.41%

  • SCU

    -0.0300

    12.72

    -0.24%

  • RBGPF

    -0.4940

    67.542

    -0.73%

  • JRI

    -0.0470

    11.273

    -0.42%

  • NGG

    0.0500

    66.26

    +0.08%

  • SCS

    -0.0400

    12.4

    -0.32%

  • RIO

    -0.4100

    68.64

    -0.6%

  • SLAC

    0.0000

    10.31

    0%

  • BCC

    -0.5200

    114.05

    -0.46%

  • GSK

    -0.2800

    36.35

    -0.77%

  • RYCEF

    -0.0565

    3.58

    -1.58%

  • BCE

    -0.0500

    40.55

    -0.12%

  • CMSD

    0.0250

    24.075

    +0.1%

  • RELX

    0.1800

    38.77

    +0.46%

  • BP

    -0.1250

    35.465

    -0.35%

  • VOD

    0.0050

    9.045

    +0.06%

  • BTI

    -0.3350

    31.595

    -1.06%

  • AZN

    -0.9500

    64.07

    -1.48%

Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma
Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma

Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma

CHARLOTTE, N.C., Nov. 16, 2023 /PRNewswire/ -- Blood Cancer UK has become Amwins Global Risks' charity partner, with the partnership expected to raise around £100,000 in the next two years. The partnership will also raise the awareness of blood cancer, which is the third biggest cancer killer in the UK.

Text size:

Amwins Global Risks is a specialist wholesale insurance and reinsurance broker serving clients and markets in the U.K. and internationally to place more than $2 billion annually of premium into the London and global marketplace.

Multiple myeloma is a type of blood cancer that affects 5,000 people in the UK every year. Matthew Wilson, a leader in the insurance industry, is one of those who is affected, after being diagnosed with the condition in 2021.

For most people, myeloma responds well to initial treatment but unfortunately it almost always comes back. The money Amwins raises will go towards the Matthew Wilson Multiple Myeloma Fund set up by Matthew and his family with Blood Cancer UK.

Speaking about the partnership, Matthew said:
"I'm thrilled that the money from Amwins will go towards life-saving blood cancer research, so we can bring forward the day we find a cure for multiple myeloma, the type of blood cancer I was diagnosed with two years ago. Hopefully, together with all those at Amwins, we can make a real difference to people's lives."

The fund has already led to the funding of two clinical research fellows, who through the pursuit of a PhD could become research leaders in multiple myeloma. One of the fellows will work on gaining more understanding about the key molecules that help myeloma cells to grow in number and thrive. And the other fellow will look to understand more about the causes of myeloma so new screening tools and drugs can be developed.

Rachel Calderon, Deputy Director of Fundraising at Blood Cancer UK, said:
"While 40,000 people are diagnosed with blood cancer every year, it remains a hidden cancer. This means that, too often, people with blood cancer don't feel that others understand what we're going through or treat the condition as seriously as they should.

"We're delighted to join forces with Amwins to improve the lives of those affected by blood cancer. With their support we can accelerate our efforts to find new treatments for the blood cancer through establishing pioneering research leaders in myeloma. And raising awareness about the challenges faced by those with blood cancer will be critical to achieving this."

Nate Mathis, CEO of Amwins Global Risks, said:
"At Amwins, we believe in making a difference beyond the world of insurance. Our collaboration with Blood Cancer UK aligns perfectly with our values and commitment to creating positive change. We are so proud to be supporting the Matthew Wilson Multiple Myeloma Fund and Blood Cancer UK in their work to beat blood cancer."

For further information contact Ed Pinches, Media Relations Manager, Blood Cancer UK, on [email protected] or on +44 20 7504 2289, or Nicola Murphy, Head of Marketing & Communications, Amwins Global Risks, on +44777 468 1085 or [email protected].

About Blood Cancer UK

Blood Cancer UK have invested £500 million in research in blood cancer since 1960. Currently the charity is funding £23m of research across 65 research projects institutions in the UK. To keep up to date with all the latest blood cancer news, go to https://bloodcancer.org.uk/news/ and find us on social media.

For free and confidential support, and information on blood cancer and life after a diagnosis, call us on 0808 2080 888 or email us at [email protected]

 Join our online forum and talk to others affected by blood cancer at forum.bloodcancer.org.uk.

About Amwins Global Risks

Amwins Global Risks is a specialist wholesale insurance and reinsurance broker serving clients and markets in the UK and internationally to place more than $2 billion annually of premium into the London and global marketplace. To learn more, visit amwinsglobalrisks.com.

(S.G.Stein--BBZ)